Health Condition 1: A309- Leprosy, unspecified
Conditions
Interventions
Intervention1: Trans-cranial Magnetic
Stimulation: Experimental group A. Steroid Therapy- patients in 1st week of steroids treatment will only be
included (according to the WHO guidelines). - TMS- TMS
Sponsors
Lovely Professional University
Eligibility
Inclusion criteria
Inclusion criteria: Clinically diagnosed leprosy patients aged between 18 to 45 years undergoing WHO- MDT therapy with Ulnar and/or Median and/or Ulnar neuritis of 6 months of duration and eligible for oral steroid therapy
Exclusion criteria
Exclusion criteria: Patients with a history of upper extremity recent fracture, history of any other neurological deficits, epilepsy, stroke, demyelinating disorders, diabetes, migraine, headache, systemic disease, on medications affecting CNS and cardiac pacemaker placement will be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EMG parameters (latency and peak-to-peak MEP amplitudes), nerve conduction velocity of both sensory and motor conduction velocities, distal latencies and amplitudeTimepoint: Before 1st treatment session and after 10th treatment session | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the muscle strength, grip strength and protective sensationTimepoint: Before 1st treatment session and after 10th treatment session | — |
Countries
India
Contacts
Public ContactAnshika Singh
Lovely Professional University
Outcome results
None listed